Lobbying activity

1A

VENABLE LLP for ASSOCIATION OF BLACK CARDIOLOGISTS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income

Health Issues

View → Q1

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate

Pharmacy

View → Q1

THE ALS ASSOCIATION for THE ALS ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Veterans

View → Q1

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues

View → Q1

VENABLE LLP for ASSOCIATION OF BLACK CARDIOLOGISTS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income

Health Issues

View → Q1

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

PUBLIC CITIZEN for PUBLIC CITIZEN

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products

View → 3A

NOVARTIS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → 2A

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → 2A

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Budget/Appropriations

View → Q4

THE ALS ASSOCIATION for THE ALS ASSOCIATION

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate

Medicare/Medicaid, Budget/Appropriations, Health Issues, Veterans

View → Q4

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

TODD STRATEGY GROUP for NOVARTIS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q4

TODD STRATEGY GROUP for ASTRAZENECA PHARMACEUTICALS LP

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid, Health Issues

View → Q4

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · $70,000.00 income

Health Issues

View → Q4

SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q4

NOVARTIS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View → Q4

AVENUE SOLUTIONS for GENENTECH USA, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

DLA PIPER LLP (US) for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Taxation/Internal Revenue Code, Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues

View → Q4

AMGEN, INC. for AMGEN INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q4

TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Medicare/Medicaid, Health Issues

View → Q4

TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

BGR GOVERNMENT AFFAIRS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate

Pharmacy

View →